Loading...
Loading...
Browse all stories on DeepNewz
VisitWhich funding agency will be the first to grant significant funding for DeepRVAT research?
NIH • 25%
European Research Council • 25%
Wellcome Trust • 25%
Other • 25%
Funding announcements, press releases
DKFZ, EMBL, TU Muenchen Develop AI Model DeepRVAT for Rare Variant Testing
Sep 26, 2024, 06:12 AM
Researchers at DKFZ, EMBL, and TU Muenchen have developed a new AI model called DeepRVAT. This model leverages deep set neural networks to integrate variant annotations, enhancing the accuracy of rare variant association testing. DeepRVAT allows for more precise distinction of individuals at high risk of disease and helps identify genes involved in disease development. The model first accounts for nonlinear effects from rare variants on gene function and then models variation in traits as linear functions of estimated gene impairment scores. This breakthrough, developed in collaboration with Holtkamp_Eva and brianfclarke, pushes the boundaries of personalized medicine by providing more accurate predictions of the effects of rare genetic variants. The model also harnesses variant annotations from models like AlphaMissense.
View original story
Government grants • 25%
Private investors • 25%
Pharmaceutical companies • 25%
Non-profit organizations • 25%
Government grants • 25%
Private investment • 25%
Philanthropic organizations • 25%
University funding • 25%
Government Grants • 25%
Private Investors • 25%
Philanthropic Organizations • 25%
Corporate Partnerships • 25%
Federal Grants • 25%
State Grants • 25%
Private Funding • 25%
RTC Budget • 25%
Government grants • 25%
Private investors • 25%
Public companies • 25%
Non-profit organizations • 25%
National Institutes of Health (NIH) • 25%
National Science Foundation (NSF) • 25%
European Research Council (ERC) • 25%
Other • 25%
Yes • 50%
No • 50%
Pentagon • 25%
CIA • 25%
NSA • 25%
Other • 25%
Government Grants • 25%
Private Sector Investment • 25%
University Funding • 25%
Other • 25%
Energy Efficiency • 25%
Renewable Energy • 25%
Nuclear Energy • 25%
Other • 25%
AI Research • 25%
Cloud Computing • 25%
Data Centers • 25%
Other • 25%
Beijing Institute of Technology • 25%
Technical University of Munich • 25%
Moscow State University • 25%
Other • 25%
No • 50%
Yes • 50%
Yes • 50%
No • 50%
Neurological Disorders • 25%
Other • 25%
Cancer • 25%
Cardiovascular Disease • 25%